ClinicalTrials.Veeva

Menu

Ultrasound to Check the Position of the Nasogastric Tube (SONUS)

D

Dr. Negrin University Hospital

Status

Enrolling

Conditions

Nasogastric Tube Placement

Treatments

Diagnostic Test: Postoperative ultrasound

Study type

Interventional

Funder types

Other

Identifiers

NCT06635915
2022-300-1

Details and patient eligibility

About

The main objective of this study is to evaluate whether the use of ultrasound as a method of checking the normal positioning of the NGT is reliable, without requiring other diagnostic tests. Clinical trial that will include patients who had the NGT placed intraoperatively. 114 patients (57 with NGT and 57 without NGT) will be examined by ultrasound in the immediate postoperative period to diagnose the normal positioning of the NGT or its absence.

Can ultrasound quickly and effectively diagnose the normal positioning of the NGT? Can chest X-ray be avoided by introducing ultrasound in the verification of the normal positioning of the NGT in the immediate postoperative period?

Full description

The nasogastric tube (NGT) is an essential element of our daily clinical practice, commonly used for the administration of enteral nutrition and medication or for gastric decompression and diagnostic procedures. Despite its common use, it is still an invasive procedure with potential complications. Ultrasound is a noninvasive, inexpensive, widely available and rapid method that can speed up the proper verification of these devices. The main objective of this study is to evaluate whether the use of ultrasound as a method of checking the normal positioning of the NGT is reliable, without requiring other diagnostic tests. Clinical trial that will include patients who had the NGT placed intraoperatively. 114 patients (57 with NGT and 57 without NGT) will be examined by ultrasound in the immediate postoperative period to diagnose the normal positioning of the NGT or its absence. Patients who have had the NGT placed will have had their NGT placed correctly by chest X-ray. The upper part of the patient will be covered for the examiner, who will only have access to the patient's abdomen and will not know which patients have NGT or not.

Enrollment

114 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients classified as ASA I-IV according to the American Society of Anesthesiologists
  • Patients over 18 years old.
  • Informed consent signed by the patient or their family representatives

Exclusion criteria

  • Patients classified as ASA V.
  • Patients under 18 years old.
  • Refusal to participate in the study.
  • Contraindication for nasogastric tube placement: ingestion of caustics, nasal or skull fractures, and cervical surgery.
  • Patients with anatomical abnormalities at the cervical or pharyngoesophageal level.

Trial design

Primary purpose

Diagnostic

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

114 participants in 2 patient groups

Patients with nasogastric tube placed during the intraoperative period.
Experimental group
Description:
Ultrasound will be performed during the postoperative period to assess the normoposition of nasogastric tube.
Treatment:
Diagnostic Test: Postoperative ultrasound
Patients without nasogastric tube placed during the intraoperative period.
Active Comparator group
Description:
Ultrasound will be performed during the postoperative period to assess the absence of nasogastric tube.
Treatment:
Diagnostic Test: Postoperative ultrasound

Trial contacts and locations

2

Loading...

Central trial contact

Aurelio Rodríguez-Pérez, MD PhD; Angel Becerra-Bolaños, MD PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems